Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4566874
Max Phase: Preclinical
Molecular Formula: C29H42FN7O9
Molecular Weight: 617.63
Molecule Type: Unknown
Associated Items:
ID: ALA4566874
Max Phase: Preclinical
Molecular Formula: C29H42FN7O9
Molecular Weight: 617.63
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCCC[C@@H](C(=O)NCNC(=O)c1cccc(-c2ccc(C(=O)N[C@@H](CC(=O)O)C(=O)O)c(F)c2)n1)[C@@H](CC)N(O)C=O.N.N
Standard InChI: InChI=1S/C29H36FN5O9.2H3N/c1-3-5-6-8-19(24(4-2)35(44)16-36)26(39)31-15-32-28(41)22-10-7-9-21(33-22)17-11-12-18(20(30)13-17)27(40)34-23(29(42)43)14-25(37)38;;/h7,9-13,16,19,23-24,44H,3-6,8,14-15H2,1-2H3,(H,31,39)(H,32,41)(H,34,40)(H,37,38)(H,42,43);2*1H3/t19-,23+,24-;;/m1../s1
Standard InChI Key: CTMLNRVMRGLLNE-DWBSNKBKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 617.63 | Molecular Weight (Monoisotopic): 617.2497 | AlogP: 2.17 | #Rotatable Bonds: 18 |
Polar Surface Area: 215.33 | Molecular Species: ACID | HBA: 8 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.13 | CX Basic pKa: 2.16 | CX LogP: 2.34 | CX LogD: -3.37 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.05 | Np Likeness Score: -0.36 |
1. (2017) Hydroxy formamide derivatives and their use, |
Source(1):